Healthcare >> Analyst Interviews >> April 3, 2000

Drug Delivery Stocks : Louis Webb – Fahnestock & Co

LOUIS C. WEBB is a Director, Equity Research at RBC Capital Markets, focusing on drug delivery and specialty pharmaceuticals as part of the Life Sciences equity research team. He has 26 years' experience following the pharmaceutical sector, including four years at Fahnestock & Co. and six years at Robert W. Baird & Co. Mr. Webb received a Bachelor of Science degree in Engineering and Applied Science from Yale University in 1975 and became a Chartered Financial Analyst in 1980. He is a member of AIMR and the NYSSA. In The Wall Street Journal Annual Analyst survey, Mr. Webb ranked first in pharmaceutical stock picking in 2000 and first in pharmaceutical earnings estimate accuracy in 1996. Mr. Webb lives in Ossining, New York, and includes sailing among his personal interests. Profile
TWST: Begin by telling us about the Fahnestock Drug Delivery Conference.

Mr. Webb: We are featuring 10 companies under coverage that are among

the most attractive developers of drug delivery